Related Experiment Video
Updated: May 22, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Urine biomarkers in juvenile-onset SLE nephritis
Louise Watson1, Michael W Beresford
1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Eaton Road, Liverpool L12 2AP, UK. louwatson2001@yahoo.com
Insights
Early detection of lupus nephritis (LN) in children is crucial. Promising novel biomarkers, like urinary neutrophil gelatinase associated lipocalin, may improve diagnosis and prevent kidney damage.
Area of Science:
- Pediatric Nephrology
- Immunology
- Biomarker Discovery
Background:
- Juvenile-onset systemic lupus erythematosus frequently involves the kidneys, with a high risk of progression to renal failure.
- Current markers for lupus nephritis (LN) activity are insufficient for predicting flares and guiding treatment.
- Kidney biopsy, the gold standard, is invasive and impractical for routine monitoring in children.
Purpose of the Study:
- To identify novel, non-invasive biomarkers for early detection and monitoring of lupus nephritis in pediatric patients.
- To explore biomarkers that can predict disease flares and assess treatment response.
- To overcome limitations of current diagnostic and monitoring methods for juvenile-onset LN.
Main Methods:
- Review of current literature on biomarkers for juvenile-onset lupus nephritis.
- Identification and evaluation of promising novel biomarkers, including urinary neutrophil gelatinase associated lipocalin, monocyte chemoattractant protein 1, and transforming growth factor-beta.
- Discussion of the need for large-scale, prospective validation studies.
Main Results:
- Several novel biomarkers show promise for detecting LN onset and activity.
- No single biomarker is unique to LN, suggesting a combination approach is necessary.
- Urinary neutrophil gelatinase associated lipocalin, monocyte chemoattractant protein 1, and transforming growth factor-beta are among the most promising candidates.
Conclusions:
- Novel biomarkers are needed to improve the early detection and management of lupus nephritis in children.
- A combination of biomarkers is likely required for comprehensive assessment of disease activity, treatment response, and prognosis.
- Further validation in large pediatric cohorts is essential to establish clinical utility.
Abstract:
Over 80 % of patients with juvenile-onset systemic lupus erythematosus will have renal involvement compared to 40 % with adult-onset disease. Up to 44 % of children who do have lupus nephritis (LN) progress to renal failure in early adulthood. Improved methods of detecting onset of LN would allow earlier treatment, which may prevent irreversible renal scarring and a decline in renal function. Current conventional markers of disease activity fail to adequately predict renal lupus flares and include proteinuria, complement levels, anti-double-stranded DNA antibodies and serum creatinine concentrations. Standardized histological classification is currently the gold standard for diagnosing and classifying LN, but its invasive nature limits routine use for monitoring, especially in a childhood population. Novel biomarkers need to be sensitive and specific-and preferably non-invasive and cost-effective. The most promising biomarkers in juvenile-onset LN include urinary neutrophil gelatinase associated lipocalin, monocyte chemoattractant protein 1 and transforming growth factor-beta, although many others have been identified and are under investigation. No one biomarker yet discovered is unique to LN, indicating an overlap in disease pathophysiology. It is likely that a combination of biomarkers will be required for assessing disease flare detection, response to treatment and prognostic information. Potential biomarkers require longitudinal validation in large paediatric, prospective cohorts to assess their ability to act as clinically useful adjuncts.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Nephrotic Syndrome III : Nursing Management
